Therapy and Diagnostic Tests Used for Helicobacter pylori Infection in the Scandinavian Countries in 1998

References

• van der Hulst RW, Keller JJ, Rauws EA, Tytgat GN. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996;1:6–19.
   PubMedGoogle Scholar
• Christensen AH, Logan RP, Noach LA, Gjorup T. Do clinicians accept the role of Helicobacter pylori in duodenal ulcer disease: a survey of European gastroenterologists and general practitioners. J Intern Med 1994;236:501–5.
   PubMedGoogle Scholar
• Babbs C. H. pylori-associated gastroduodenal disease: survey of British physicians’ views. Gut 1995;37 Suppl 1:347.
   Google Scholar
• Boekema PJ, Veenendaal RA, van Berge-Henegouwen GP. After a decade of Helicobacter pylori in The Netherlands. A survey of the practice of the members of the Dutch Society of Gastroenterology. Neth J Med 1997;51:129–33.
   Google Scholar
• Fendrick AM, Hirth RA, Chernew ME. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996;91: 1544–8.
   Google Scholar
• Breuer T, Goodman KJ, Malaty HM, Sudhop T, Graham DY. How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol 1998;93:553–61.
   Google Scholar
• Breuer T, Sudhop T, Goodman KJ, Graham DY, Malfertheiner P. How do practicing clinicians manage Helicobacter pylori-related gastrointestinal diseases in Germany? A survey of gastroenterologists and family practitioners. Helicobacter 1998; 3:1–8.
   Google Scholar
• Norsk oppdateringskonferanse om behandling av Helicobacter pylori ved ulcus pepticum. [A Norwegian conference on updating of the treatment of Helicobacter pylori in peptic ulcer. Interessegruppe for Gastroenterologi.] Tidsskr Nor Laegeforen 1994;114:2495–7.
   PubMedGoogle Scholar
• Läkemedelsverket: Behandling av Helicobacter pylori-infektioner, rekommendationer. Inform Lakemedelsverket 1996;7: 65–9.
   Google Scholar
• Farkilla M, Julkunen R, Niemala S, Nuutinen H, Kosunen T, Karvonen A, et al. Helicobacter pylori-infektion dignostiikasta, hoidostaja seurannasta. Suom Laakaril 1996;51:9–13.
   Google Scholar
• Malfertheiner P, Megraud F, O’Morain C, Bell D, Bianchi Porro G, Deltenre M, et al. Current European concepts in the management of Helicobacter pylori infection—the Maastricht Consensus Report. The European Helicobacter pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997;9:1–2.
   Google Scholar
• NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65–9.
   PubMed Web of Science ®Google Scholar
• Rabenek L, Graham D. Helicobacter pylori: when to test, when to treat [editorial]. Ann Intern Med 1997;126:315–6.
   PubMedGoogle Scholar
• Buckley M, O’Morain C. Helicobacter pylori eradication—a surrogate marker for duodenal ulcer healing [comment]. Eur J Gastroenterol Hepatol 1996;8:415–6.
   PubMedGoogle Scholar
• Miehlke S, Bayerdorffer E, Lehn N, Mannes GA, Hochter W, Weingart J, et al. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:975–8.
   PubMed Web of Science ®Google Scholar
• Labenz J, Tillenburg B, Peitz U, Borsch G. Long-term consequences of Helicobacter pylori eradication: clinical aspects. Scand J Gastroenterol 1996;31 Suppl 215:111–5.
   PubMedGoogle Scholar
• Berstad A, Hatlebakk JG, Wilhelmsen I, Berstad K, Bang CJ, Nysaeter G, et al. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection. Hepatogastroenterology 1995;42:655–9.
   PubMedGoogle Scholar
• Zanten SJOVv, Talley NJ. Should antibiotic treatment of Helicobacter-positive patients with non-ulcer dyspepsia now be recommended? Eur J Gastroenterol Hepatol 1998;10:367–70.
   Google Scholar
• O’Connor HJ, Cunnane K. Helicobacter pylori and gastro-oesophageal reflux disease—a prospective study. Ir J Med Sci 1994;163: 369–73.
   Google Scholar
• Lee J, Breslin N, O’Morain C. Is there an association between Helicobcter pylori infection and reflux oesophagitis? Ir J Med Sci 1996;165 Suppl 4:A10.
   Google Scholar
• Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442–7.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Leidman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication [see comments]. N Engl J Med 1996;334:1018–22.
   Google Scholar
• Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997;41:740–7.
   Google Scholar
• FDA Omeprazole description, no 791092728, issued June 1998. Federal and Drug Administration’s database on the Internet (http://www.fda.gov); 1998.
   Google Scholar
• Labenz J, Gyenes E, Ruhl GH, Borsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study [see comments]. Gut 1993;34:1167–70.
   PubMed Web of Science ®Google Scholar
• Graham KS, Malaty H, el-Zimaity HM, Genta RM, Cole RA, al- Assi MT, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995;90:1415–8.
   Google Scholar
• Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance [see comments]. N Engl J Med 1997;337: 441–6.
   Google Scholar
• Lerang F, Moum B, Haug JB, Berge T, Tolas P, Sandvei PK, et al. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Scand J Gastroenterol 1997;32:1209–14.
   PubMed Web of Science ®Google Scholar
• van der Hulst RW, van der Ende A, Homan A, Roorda P, Dankert J, Tytgat GN. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut 1998;42:166–9.
   PubMedGoogle Scholar
• Lerang F, Haug JB, Moum B, Mowinckel P, Berge T, Ragnhildstveit E, et al. Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. Scand J Gastroenterol 1998;33:710–5.
   PubMed Web of Science ®Google Scholar
• Lerang F, Moum B, Mowinckel P, Haug JB, Ragnhildstveit E, Berge T, et al. Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results. Scand J Gastroenterol 1998;33: 364–9.
   PubMed Web of Science ®Google Scholar